Comparison of the efficacy of ivermectin cream and ketoconazole cream in treatment of facial seborrheic dermatitis
Phase 3
Recruiting
- Conditions
- Facial seborrheic dermatitis.Seborrheic dermatitis, unspecifiedL21.9
- Registration Number
- IRCT20210222050452N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients more than 18 years old
Clinical diagnosis of seborrheic dermatitis (erythematous plaques with greasy and yellowish scales on nose, nasolabial fold, forehead, frown lines, cheek and chin)
Exclusion Criteria
?Severe facial seborrheic dermatitis
Using antibiotics or immunomodulatory drugs since one month before beginning of the research
Using any topical drugs that can affect seborrheic dermatitis since two weeks before beginning of the study
Using any oral drugs that can affect seborrheic dermatitis since one month before beginning of the research
Human immunodeficiency virus infection
Pregnancy
Sensitivity to the research drugs constituents
Parkinson'sdisease
Lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method